The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - PharmaMar; Tesaro
Long-lasting, irreversible and late-onset immune-related adverse events (irAEs) from immune checkpoint inhibitors (ICIs): A real-world data analysis.
 
Eleonora Ghisoni
No Relationships to Disclose
 
Alexandre M Wicky
No Relationships to Disclose
 
Sofiya Latifyan
No Relationships to Disclose
 
Nuria Neisy Mederos Alfonso
Consulting or Advisory Role - AstraZeneca
 
Berna C. Özdemir
No Relationships to Disclose
 
Michel A Cuendet
No Relationships to Disclose
 
Martina Imbimbo
No Relationships to Disclose
 
Laura Marandino
Travel, Accommodations, Expenses - Sanofi
 
Julie Delyon
Research Funding - MSD
Travel, Accommodations, Expenses - Pierre Fabre; Roche
 
Camille Lea Gerard
No Relationships to Disclose
 
Erica Tavazzi
No Relationships to Disclose
 
Roberto Gatta
Research Funding - Merck Serono (Inst)
 
Giorgio Valabrega
No Relationships to Disclose
 
Massimo Aglietta
Consulting or Advisory Role - Bayer; BMSi; Merck; Novartis
Research Funding - AstraZeneca; PharmaMar
Travel, Accommodations, Expenses - BMSi; Merck; Tesaro
 
Michel Obeid
No Relationships to Disclose
 
George Coukos
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche/Genentech
Speakers' Bureau - Roche
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Geneos (Inst); Iovance Biotherapeutics (Inst); Kite, a Gilead company (Inst); NextCure (Inst); Roche (Inst); Sanofi/Aventis (Inst)
Patents, Royalties, Other Intellectual Property - George Coukos has patents in the domain of antibodies and vaccines targeting the tumor vasculature as well as technologies related to T-cell expansion and engineering for T-cell therapy. George Coukos receives royalties from the University of Pennsylvania (Inst)
 
Solange Peters
Honoraria - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Illumina (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Biocartis (Inst); Bioinvent (Inst); Blueprint Medicines; Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo; Debiopharm Group (Inst); Illumina (Inst); Incyte; Janssen (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Takeda (Inst); Vaccibody (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Biodesix (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Illumina (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Incyte; MSD; Roche; Sanofi
(OPTIONAL) Uncompensated Relationships - ESMO; European Thoracic Oncology Platform (ETOP); Journal of Thoracic Oncology
 
Massimo Di Maio
Honoraria - AstraZeneca; Bristol-Myers Squibb; Eisai; Janssen; Mediolanum Farmaceutici; Merck Sharp & Dohme; Pfizer; Takeda
Consulting or Advisory Role - AstraZeneca; Eisai; Janssen; Mediolanum Farmaceutici; Merck Sharp & Dohme; Pfizer; Takeda
Research Funding - Tesaro (Inst)
 
Hasna Bouchaab
Consulting or Advisory Role - AstraZeneca; BMSi; MSD; Roche
Speakers' Bureau - BMSi; MSD; Roche
Travel, Accommodations, Expenses - AstraZeneca; BMSi; MSD; Roche
 
Olivier Michielin
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; MSD; NeraCare GmbH
Expert Testimony - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD